This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2226) Health Coaching for Diabetes Patients (142) Glucose Tracking and Self-Monitoring of Blood Glucose (152) Diabetes Self-Management (464)

Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43535, first published .
Improvement of Selected Psychological Parameters and Quality of Life of Patients With Type 1 Diabetes Mellitus Undergoing Transition From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to the MiniMed 780G Advanced Hybrid Closed-Loop System: Post hoc Analysis of a Randomized Control Study

Improvement of Selected Psychological Parameters and Quality of Life of Patients With Type 1 Diabetes Mellitus Undergoing Transition From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to the MiniMed 780G Advanced Hybrid Closed-Loop System: Post hoc Analysis of a Randomized Control Study

Improvement of Selected Psychological Parameters and Quality of Life of Patients With Type 1 Diabetes Mellitus Undergoing Transition From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to the MiniMed 780G Advanced Hybrid Closed-Loop System: Post hoc Analysis of a Randomized Control Study

Authors of this article:

Katarzyna Cyranka1, 2, 3 Author Orcid Image ;   Bartłomiej Matejko1, 3 Author Orcid Image ;   Anna Juza4, 5 Author Orcid Image ;   Beata Kieć-Wilk3 Author Orcid Image ;   Sabina Krzyżowska3 Author Orcid Image ;   Ohad Cohen6 Author Orcid Image ;   Julien Da Silva7 Author Orcid Image ;   Maxim Lushchyk8 Author Orcid Image ;   Maciej T Malecki1, 3 Author Orcid Image ;   Tomasz Klupa1, 3 Author Orcid Image
Article Authors Cited by (8) Tweetations (2) Metrics

Journals

  1. Bassi M, Franzone D, Dufour F, Strati M, Scalas M, Tantari G, Aloi C, Salina A, d’Annunzio G, Maghnie M, Minuto N. Automated Insulin Delivery (AID) Systems: Use and Efficacy in Children and Adults with Type 1 Diabetes and Other Forms of Diabetes in Europe in Early 2023. Life 2023;13(3):783 View
  2. Edd S, Castañeda J, Choudhary P, Kolassa R, Keuthage W, Kroeger J, Thivolet C, Evans M, Ré R, Cellot J, de Portu S, Vorrink L, Shin J, van den Heuvel T, Cohen O. Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes. Diabetes, Obesity and Metabolism 2023;25(11):3212 View
  3. Nuzzo M, Schettino M. Advanced Technology (Continuous Glucose Monitoring and Advanced Hybrid Closed-Loop Systems) in Diabetes from the Perspective of Gender Differences. Diabetology 2023;4(4):519 View
  4. Cyranka K, Matejko B, Juza A, Kieć-Wilk B, Cohen O, Malecki M, Klupa T. Quality of life in the course of a one-year use of an advanced hybrid closed-loop system in adults with type 1 diabetes previously naïve to advanced diabetes technology. Frontiers in Endocrinology 2023;14 View
  5. Matejko B, Juza A, Kieć-Wilk B, Cyranka K, Krzyżowska S, Cohen O, Malecki M, Klupa T. One-Year Follow-Up of Advanced Hybrid Closed-Loop System in Adults with Type 1 Diabetes Previously Naive to Diabetes Technology: The Effect of Switching to a Calibration-Free Sensor. Diabetes Technology & Therapeutics 2023;25(8):554 View
  6. South C, Talbo M, Roy-Fleming A, Peters T, Nielsen D, Iceta S, Brazeau A. Does Insulin Delivery Technology Change Our Relationship with Foods? A Scoping Review. Diabetes Technology & Therapeutics 2024;26(2):136 View
  7. McClure R, Talbo M, Bonhoure A, Molveau J, South C, Lebbar M, Wu Z. Exploring Technology’s Influence on Health Behaviours and Well-being in Type 1 Diabetes: a Review. Current Diabetes Reports 2024;24(4):61 View
  8. Chibane S, Berot A, Lukas‐croisier C, Dollez L, Barraud S, Delemer B, Vitellius G. Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020. Journal of Diabetes Investigation 2024 View